Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets

Vox Sanguinis

Volumn 102, Issue 2, 2012, Pages 100-109

  Cooper, J K ^a   Ladhani, K ^a   Minor, P ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Blood; Diagnostic; Plasma; Sensitivity; VCJD

Indexed keywords

PRION PROTEIN;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; BLOOD COMPONENT; CHEMOLUMINESCENCE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DILUTION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IN VITRO STUDY; LABORATORY TEST; LIMIT OF DETECTION; PRION DISEASE; PRIORITY JOURNAL; REPRODUCIBILITY; SINGLE BLIND PROCEDURE; TISSUE HOMOGENATE;

BIOLOGICAL MARKERS; BLOOD DONORS; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; DETERGENTS; HUMANS; PLASMA; PRIONS; SPLEEN;

EID: 84856008271     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01525.x     Document Type: Article

References (23)

1. Diener TO, McKinley MP, Prusiner SB: Viroids and prions. Proc Natl Acad Sci U S A 1982; 79:5220-5224.
2. Prusiner SB: Molecular biology of prion diseases. Science 1991; 252:1515-1522.
3. Hill AF, Desbruslais M, Joiner S, et al.: The same prion strain causes vCJD and BSE. Nature 1997; 389:448-450.
4. Bruce ME, Will RG, Ironside JW, et al.: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389:498-501.
5. Hewitt PE, Llewelyn CA, Mackenzie J, et al.: Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91:221-230.
6. Peden AH, Head MW, Ritchie DL, et al.: Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527-529.
7. Llewelyn CA, Hewitt PE, Knight RS, et al.: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417-421.
8. Wroe SJ, Pal S, Siddique D, et al.: Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006; 368:2061-2067.
9. Editorial Team. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 2007;12: pii. 3117.
10. Peden A, McCardle L, Head MW, et al.: Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16:296-304.
11. Kaski D, Mead S, Hyare H, et al.: Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009; 374:2128.
12. Hilton DA, Ghani AC, Conyers L, et al.: Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203:733-739.
13. Clewley JP, Kelly CM, Andrews N, et al.: Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009; 338:b1442.
14. de Marco MF, Linehan J, Gill ON, et al.: Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol 2010; 222:380-387.
15. Gregori L, McCombie N, Palmer D, et al.: Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004; 364:529-531.
16. Sowemimo-Coker SO, Pesci S, Andrade F, et al.: Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sang 2006; 90:265-275.
17. Gregori L, Gurgel PV, Lathrop JT, et al.: Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 2006; 368:2226-2230.
18. Minor P, Brown P. Diagnostic tests for CJD for ante-mortem screening. Chapter 5; in Turner ML, (ed.): Creutzfeldt-Jakob Disease: Managing the Risk of Transmission by Blood, Plasma, and Tissues. Bethesda, MD, AABB Press Publisher, 2006: 119-48.
19. Edgeworth JA, Farmer M, Sicilia A, et al.: Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377:487-493.
20. Minor P, Newham J, Jones N, et al.: Standards for the assay of Creutzfeldt-Jakob disease specimens. J Gen Virol 2004; 85:1777-1784.
21. Cooper JK, Ladhani K, Minor PD: Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays. Vox Sang 2007; 92:302-310.
22. Bellon A, Seyfert-Brandt W, Lang W, et al.: Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol 2003; 84:1921-1925.
23. Lau AL, Yam AY, Michelitsch MM, et al.: Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC. Proc Natl Acad Sci U S A 2007; 104:11551-11556.